Zydus Lifesciences has secured final approval from the USFDA for its generic Eltrombopag tablets. These tablets treat low platelet counts in specific blood disorders. The approval covers multiple strengths. Production will occur at the company's Ahmedabad facility. This development marks a significant step for Zydus in the US market.
